KERİMOĞLU, O. Et Al. 2013. MATRIX TYPE TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING CAPTOPRIL: FORMULATION OPTIMIZATION, IN VITRO AND EX VIVO CHARACTERIZATION. ACTA POLONIAE PHARMACEUTICA , vol.70, no.2 , 291-300.

KERİMOĞLU, O., Keskin, E., Dortunc, B., & Anah, S., (2013). MATRIX TYPE TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING CAPTOPRIL: FORMULATION OPTIMIZATION, IN VITRO AND EX VIVO CHARACTERIZATION. ACTA POLONIAE PHARMACEUTICA , vol.70, no.2, 291-300.

KERİMOĞLU, OYA Et Al. "MATRIX TYPE TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING CAPTOPRIL: FORMULATION OPTIMIZATION, IN VITRO AND EX VIVO CHARACTERIZATION," ACTA POLONIAE PHARMACEUTICA , vol.70, no.2, 291-300, 2013

KERİMOĞLU, OYA Et Al. "MATRIX TYPE TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING CAPTOPRIL: FORMULATION OPTIMIZATION, IN VITRO AND EX VIVO CHARACTERIZATION." ACTA POLONIAE PHARMACEUTICA , vol.70, no.2, pp.291-300, 2013

KERİMOĞLU, O. Et Al. (2013) . "MATRIX TYPE TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING CAPTOPRIL: FORMULATION OPTIMIZATION, IN VITRO AND EX VIVO CHARACTERIZATION." ACTA POLONIAE PHARMACEUTICA , vol.70, no.2, pp.291-300.

@article{article, author={OYA KERİMOĞLU Et Al. }, title={MATRIX TYPE TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING CAPTOPRIL: FORMULATION OPTIMIZATION, IN VITRO AND EX VIVO CHARACTERIZATION}, journal={ACTA POLONIAE PHARMACEUTICA}, year=2013, pages={291-300} }